Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease

Initial sirolimus dosage recommendations for pediatric patients with PIK3CD mutation-related immunodeficiency disease

Sirolimus is used to treat pediatric patients with PIK3CD mutation-related immunodeficiency disease. However, the initial dosages of sirolimus remain undecided. The present study aims to explore initial dosages in pediatric patients with PIK3CD mutation-related immunodeficiency disease. Pediatric pa...

Full description

Bibliographic Details
Main Authors:	Xiao Chen, Jinglin Wang, Jianger Lan, Xilin Ge, Hong Xu, Yu Zhang, Zhiping Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Pharmacology
Subjects:	sirolimus PIK3CD mutation immunodeficiency disease initial dosages recommendation pediatric patients
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.919487/full

Similar Items

Initial Dosage Recommendation for Sirolimus in Children With Tuberous Sclerosis Complex
by: Dong-Dong Wang, et al.
Published: (2020-06-01)

Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus
by: Zuopeng Wang, et al.
Published: (2023-05-01)

Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
by: Shixiao Dong, et al.
Published: (2023-09-01)

Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase δ syndrome 1
by: Lu Jiang, et al.
Published: (2023-09-01)

Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
by: Xiao Chen, et al.
Published: (2021-11-01)

A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
by: Guillaume Canaud, et al.
Published: (2021-07-01)

Lymphedema attributed to sirolimus
by: Ardalan Mohammad-Reza
Published: (2013-04-01)

Case Report: Activating PIK3CD Mutation in Patients Presenting With Granulomatosis With Polyangiitis
by: Meiping Lu, et al.
Published: (2021-04-01)

Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
by: Gillian L. Dornan, et al.
Published: (2018-03-01)

Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype
by: Peiwei Zhao, et al.
Published: (2024-01-01)

A somatic mutation in PIK3CD unravels a novel candidate gene for lymphatic malformation
by: Shengcai Wang, et al.
Published: (2021-05-01)

Pancreatic Kaposiform Hemangioendothelioma Not Responding to Sirolimus
by: Paloma Junco Triana, et al.
Published: (2017-01-01)

Case Report: Intestinal Nodular Lymphoid Hyperplasia as First Manifestation of Activated PI3Kδ Syndrome Due to a Novel PIK3CD Variant
by: Antonio Marzollo, et al.
Published: (2021-10-01)

Effects of sirolimus on Lung function in patients with Lymphangioleiomyomatosis
by: Fatemeh Aghaeimeybodi, et al.
Published: (2019-01-01)

Results of multicenter testing of PIK3CA somatic mutations in hormone-receptor positive HER2-negative advanced breast cancer
by: Snježana Ramić, et al.
Published: (2023-01-01)

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
by: Katherine E. Hutchinson, et al.
Published: (2023-04-01)

Dissection of <i>PIK3CA</i> Aberration for Cervical Adenocarcinoma Outcomes
by: Tony K. H. Chung, et al.
Published: (2021-06-01)

Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - A case report
by: Ajay Kumar Verma, et al.
Published: (2018-01-01)

Subconjunctival Sirolimus-Loaded Liposomes for the Treatment of Moderate-to-Severe Dry Eye Disease
by: Salcedo-Ledesma A, et al.
Published: (2023-05-01)

The Effects of Lyophilization on the Physico-Chemical Stability of Sirolimus Liposomes
by: Parvin Zakeri-Milani, et al.
Published: (2013-02-01)

Frequency and spectrum of PIK3CA somatic mutations in breast cancer
by: Olga Martínez-Sáez, et al.
Published: (2020-05-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

Low-dose sirolimus in retroperitoneal lymphangioleiomyomas
by: Kamonpun Ussavarungsi, et al.
Published: (2019-01-01)

CLOVES syndrome caused by mosaic mutation in the PIK3CA gene identified in fibroblasts
by: Magdalena Kłaniewska, et al.
Published: (2021-07-01)

Toxic effects of sirolimus and everolimus on the development and behavior of zebrafish embryos
by: Zixin Zhang, et al.
Published: (2023-10-01)

A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis
by: Akiko Kanto, et al.
Published: (2021-03-01)

Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion
by: Rósley Weber Alvarenga Fernandes, et al.
Published: (2012-04-01)

Sirolimus Induced Toxic Optic Neuropathy
by: Pakravan P, et al.
Published: (2023-05-01)

Gorham-Stout Disease with Clinical Response to Sirolimus Treatment
by: Santiago Forero Saldarriaga, et al.
Published: (2021-08-01)

Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review
by: Zixin Zhang, et al.
Published: (2022-08-01)

The Effects of Sirolimus and Magnesium on Primary Human Coronary Endothelial Cells: An In Vitro Study
by: Giorgia Fedele, et al.
Published: (2023-02-01)

Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations
by: Hongrui Chen, et al.
Published: (2023-07-01)

Highly frequent <it>PIK3CA </it>amplification is associated with poor prognosis in gastric cancer
by: Shi Jing, et al.
Published: (2012-02-01)

Activated PI3Kinase Delta Syndrome—A Multifaceted Disease
by: Romane Thouenon, et al.
Published: (2021-06-01)

Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature
by: Behzad Einollahi, et al.
Published: (2014-07-01)

A case of lymphangioma circumscriptum successfully treated with topical sirolimus
by: Malik Güngör, et al.
Published: (2024-03-01)

PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients
by: Flavia R. Mangone, et al.
Published: (2012-11-01)

Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent EGFR and PIK3CA Mutations: A Case Report and Literature Review
by: Wu Y, et al.
Published: (2021-09-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient
by: Resham J Vasani
Published: (2015-01-01)